CAS 58558-08-0
:Saikosaponin B1
Description:
Saikosaponin B1 is a triterpenoid saponin primarily derived from the roots of the plant Bupleurum falcatum, commonly known for its use in traditional medicine. This compound is characterized by its complex structure, which includes a steroid-like backbone and sugar moieties, contributing to its biological activity. Saikosaponin B1 exhibits various pharmacological properties, including anti-inflammatory, hepatoprotective, and immunomodulatory effects. It has been studied for its potential in treating liver diseases and enhancing immune responses. The compound is typically soluble in water and organic solvents, which facilitates its extraction and application in herbal formulations. Additionally, Saikosaponin B1 has shown promise in research related to cancer therapy, as it may induce apoptosis in certain cancer cell lines. Its safety profile and efficacy continue to be evaluated in clinical studies, highlighting its significance in both traditional and modern medicinal practices. Overall, Saikosaponin B1 represents a valuable compound with diverse therapeutic potentials.
Formula:C42H68O13
InChI:InChI=1S/C42H68O13/c1-21-29(47)34(55-35-32(50)31(49)30(48)24(18-43)53-35)33(51)36(52-21)54-28-11-12-38(4)25(39(28,5)19-44)10-13-40(6)26(38)9-8-22-23-16-37(2,3)14-15-42(23,20-45)27(46)17-41(22,40)7/h8-9,21,24-36,43-51H,10-20H2,1-7H3/t21-,24-,25-,26-,27+,28+,29+,30-,31+,32-,33-,34+,35+,36+,38+,39+,40-,41-,42-/m1/s1
InChI key:InChIKey=WRYJYFCCMSVEPQ-MNIDVGFKSA-N
SMILES:C[C@]12C(=C3[C@@](CO)([C@@H](O)C1)CCC(C)(C)C3)C=C[C@]4([C@@]2(C)CC[C@@]5([C@]4(C)CC[C@H](O[C@H]6[C@H](O)[C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@@H](O)[C@@H](C)O6)[C@]5(CO)C)[H])[H]
Synonyms:- (3b,4a,16b)-16,23,28-Trihydroxyoleana-11,13(18)-dien-3-yl-6-deoxy-3-O-beta-D-glucopyranosyl-beta-D-galactopyranoside
- (3beta,16beta)-16,23,28-trihydroxyoleana-11,13(18)-dien-3-yl 6-deoxy-3-O-beta-D-glucopyranosyl-beta-D-galactopyranoside
- (3beta,9xi,16beta)-16,23,28-trihydroxyoleana-11,13(18)-dien-3-yl 3-O-(6-deoxy-beta-D-glucopyranosyl)-beta-D-galactopyranoside
- (3β,4α,16β)-16,23,28-Trihydroxyoleana-11,13(18)-dien-3-yl 6-deoxy-3-O-β-<span class="text-smallcaps">D</smallcap>-glucopyranosyl-β-<smallcap>D</span>-galactopyranoside
- Saikosaponin B<sub>1</sub>
- β-<span class="text-smallcaps">D</smallcap>-Galactopyranoside, (3β,4α,16β)-16,23,28-trihydroxyoleana-11,13(18)-dien-3-yl 6-deoxy-3-O-β-<smallcap>D</span>-glucopyranosyl-
- Saikosaponin B1
- (3β,4α,16β)-16,23,28-Trihydroxyoleana-11,13(18)-dien-3-yl 6-deoxy-3-O-β-D-glucopyranosyl-β-D-galactopyranoside
- β-D-Galactopyranoside, (3β,4α,16β)-16,23,28-trihydroxyoleana-11,13(18)-dien-3-yl 6-deoxy-3-O-β-D-glucopyranosyl-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
b-D-Galactopyranoside,(3b,4a,16b)-16,23,28-trihydroxyoleana-11,13(18)-dien-3-yl6-deoxy-3-O-b-D-glucopyranosyl-
CAS:Formula:C42H68O13Purity:98%Color and Shape:SolidMolecular weight:780.9815Saikosaponin B1
CAS:Saikosaponin B1 may be as anti-schizophrenic candidate drugs, it can suppress the signal transduction after binding of EGF.Formula:C42H68O13Purity:95%~99%Molecular weight:780.993Saikosaponin B1
CAS:<p>Saponin activator. Activates release of Prostaglandin E2 in vitro. Anti-inflammatory agent. Orally active. Active in vivo and in vitro.</p>Formula:C42H68O13Purity:98.07% - 99.7%Color and Shape:SolidMolecular weight:780.98Saikosaponin b1
CAS:Natural glycosideFormula:C42H68O13Purity:≥ 90.0 % (HPLC)Color and Shape:PowderMolecular weight:781Saikosaponin B1
CAS:<p>Saikosaponin B1 is a triterpenoid saponin, which is primarily derived from the roots of Bupleurum species, particularly Bupleurum falcatum. This bioactive compound exhibits a plethora of pharmacological activities through various modes of action, including modulation of immune responses and inhibition of inflammatory pathways. It interacts with cellular components to influence signal transduction mechanisms that are crucial in the pathophysiology of various diseases.</p>Purity:Min. 95%






